Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SW-682 |
Synonyms | |
Therapy Description |
SW-682 is a small molecule pan-TEAD inhibitor, which reduces target gene expression and potentially decreases tumor growth (Cancer Res (2023) 83 (7_Supplement): 4964). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SW-682 | SW 682|SW682 | SW-682 is a small molecule pan-TEAD inhibitor, which reduces target gene expression and potentially decreases tumor growth (Cancer Res (2023) 83 (7_Supplement): 4964). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06251310 | Phase I | SW-682 | SW-682 in Advanced Solid Tumors | Recruiting | USA | 0 |